Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Almond Intake on Cardiometabolic Risk Factors, Inflammatory Markers, and Liver Enzymes: A Systematic Review and Meta-Analysis Publisher Pubmed



Morvaridzadeh M1 ; Qorbani M2, 3 ; Shokati Eshkiki Z4 ; Estevao MD5 ; Mohammadi Ganjaroudi N6 ; Toupchian O7 ; Abdollahi S7 ; Pizarro AB8 ; Abuzaid A9 ; Zadro JR10 ; Heshmati J1 ; Ziaei S11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Songhor Healthcare Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  3. 3. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Alimentary Tract Research Center, Clinical Science Reseaech Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  5. 5. Escola Superior de Saude, Universidade do Algarve, Faro, Portugal
  6. 6. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Department of Nutrition and Public Health, School of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran
  8. 8. Clinical Research Center, Fundacion Valle del Lili, Cali, Colombia
  9. 9. Department of Pharmacology, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, United States
  10. 10. Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia
  11. 11. Anesthesiologist, ICU Department, Emam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Source: Phytotherapy Research Published:2022


Abstract

Almond intake may be correlated with improvements in several cardiometabolic parameters, but its effects are controversial in the published literature, and it needs to be comprehensively summarized. We conducted a systematic search in several international electronic databases, including MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov until April 2021 to identify randomized controlled trials that examined the effects of almond consumption on cardiometabolic risk factors, inflammatory markers, and liver enzymes. Data were pooled using the random-effects model method and presented as standardized mean differences (SMDs) with 95% confidence intervals (CIs). Twenty-six eligible trials were analyzed (n = 1750 participants). Almond intake significantly decreased diastolic blood pressure, total cholesterol, triglyceride, low-density lipoprotein (LDL), non-high-density lipoprotein (HDL), and very LDL (p < 0.05). The effects of almond intake on systolic blood pressure, fasting blood glucose, insulin, hemoglobin A1c, homeostatic model assessment of insulin resistance, C-peptide, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, C-reactive protein (CRP), hs-CRP (high sensitivity C-reactive protein), interleukin 6, tumor necrosis factor-α, ICAM (Intercellular Adhesion Molecule), VCAM (Vascular Cell Adhesion Molecule), homocysteine, HDL, ox-LDL, ApoA1, ApoB, and lipoprotien-a were not statistically significant (p >.05). The current body of evidence supports the ingestion of almonds for their beneficial lipid-lowering and antihypertensive effects. However, the effects of almonds on antiinflammatory markers, glycemic control, and hepatic enzymes should be further evaluated via performing more extensive randomized trials. © 2022 John Wiley & Sons Ltd.
Other Related Docs
45. The Prevalence of Malnutrition in Iranian Elderly: A Review Article, Iranian Journal of Public Health (2017)